Table 1.
SBRT DIBH patient information. “N° of MU” shows the MU number for the overall treatment course. The “treatment time (min)” presents the median and the interquartile range (Q1 -Q3) of the treatment time.
| Patient No | Tumor Localisation | Sex | Age | Weight (kg) | PTV FB (cm3) | PTV DIBH (cm3) | Dose (Gy) | N° fraction | N° arcs | N° of MU/fraction | Anterior SSD (cm) | Treatment time (min) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Upper lobe | Female | 81 | 71 | 41.7 | 22.3 | 55 | 5 | 6 | 9688 | 86.3 | 26.4 (17.9–30.1) |
| 2 | Inferior lobe | Male | 75 | 92 | 55.9 | 18.7 | 52.5 | 7 | 6 | 1712 | 80.1 | 15.8 (14.4–23.8) |
| 3 | Inferior lobe | Male | 77 | 71 | 25.4 | 21.7 | 55 | 5 | 6 | 2728 | 91.7 | 22.4 (22.3–27.5) |
| 4 | Inferior lobe | Male | 86 | 74 | 26.1 | 13.9 | 55 | 5 | 4 | 2592 | 81.1 | 21.9 (21.9–22.8) |
| 5 | Inferior lobe | Male | 86 | 74 | – | 20.6 | 55 | 5 | 6 | 3067 | 80.8 | 16.7 (15.1–19.2) |
| 6 | Inferior lobe | Male | 54 | 55 | 8.6 | 5.7 | 50 | 5 | 4 | 1774 | 86.3 | 23.9 (19.9–27.4) |
| 7 | Inferior lobe | Male | 54 | 55 | – | 78.9 | 50 | 5 | 4 | 2227 | 88.3 | 18.9 (14.5–21.7) |
| 8 | Upper lobe | Male | 86 | 76 | – | 21.7 | 60 | 8 | 6 | 3230 | 89 | 20.2 (20–21.6) |
| 9 | Middle lobe | Female | 79 | 107 | 21.9 | 17.5 | 60 | 8 | 6 | 3617 | 86.9 | 28.8 (25.8–31.4) |
| 10 | Inferior lobe | Male | 65 | 60 | 9.6 | 7.6 | 50 | 5 | 4 | 2319 | 88.3 | 14.4 (12.5–15.1) |
| 11 | Inferior lobe | Male | 79 | 72 | 51.4 | 45.7 | 55 | 5 | 6 | 2375 | 85.6 | 24.2 (18.8–25.1) |
| 12 | Middle lobe | Female | 44 | 102 | 90.4 | 68.3 | 55 | 5 | 6 | 3519 | 81.9 | 20.8 (19.6–24.6) |
| 13 | Upper lobe | Male | 86 | 74 | 77.6 | 47 | 55 | 5 | 4 | 2149 | 80.9 | 20.7 (18.4–20.9) |
Abbreviations: PTV: planning target volume, FB: free breathing, DIBH: deep inspiration breath-hold.